Initiator Pharma Statistics

Total Valuation

Initiator Pharma has a market cap or net worth of SEK 374.02 million. The enterprise value is 351.96 million.

Market Cap	374.02M
Enterprise Value	351.96M

Important Dates

The next estimated earnings date is Friday, November 29, 2024.

Earnings Date	Nov 29, 2024
Ex-Dividend Date	n/a

Share Statistics

Initiator Pharma has 56.24 million shares outstanding. The number of shares has increased by 3.02% in one year.

Current Share Class	n/a
Shares Outstanding	56.24M
Shares Change (YoY)	+3.02%
Shares Change (QoQ)	+6.82%
Owned by Insiders (%)	9.35%
Owned by Institutions (%)	12.01%
Float	36.53M

Valuation Ratios

PE Ratio	n/a
Forward PE	5.94
PS Ratio	n/a
PB Ratio	12.94
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-19.11
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 15.40

Current Ratio	15.40
Quick Ratio	15.40
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -72.71% and return on invested capital (ROIC) is -48.81%.

Return on Equity (ROE)	-72.71%
Return on Assets (ROA)	-43.56%
Return on Capital (ROIC)	-48.81%
Revenue Per Employee	n/a
Profits Per Employee	-6.14M
Employee Count	3
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -29.41% in the last 52 weeks. The beta is 0.75, so Initiator Pharma's price volatility has been lower than the market average.

Beta (5Y)	0.75
52-Week Price Change	-29.41%
50-Day Moving Average	7.21
200-Day Moving Average	8.47
Relative Strength Index (RSI)	45.17
Average Volume (20 Days)	25,770

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	-20.95M
Operating Income	-27.47M
Pretax Income	-25.78M
Net Income	-18.42M
EBITDA	n/a
EBIT	-27.47M
Earnings Per Share (EPS)	-0.34

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	22.06M
Total Debt	n/a
Net Cash	22.06M
Net Cash Per Share	0.39
Equity (Book Value)	28.81M
Book Value Per Share	0.51
Working Capital	28.78M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-23.66M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Initiator Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.02%
Shareholder Yield	-3.02%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a